By: Erin Michael, Christine Klimanskis
Use of anti-VEGF therapies varies by both U.S. Census region and patient population, according to research presented at the American Academy of Ophthalmology meeting.
Erin Michael is a Senior Editorial Features Manager at Healio. She specializes in medicine and healthcare, with a focus on topics such as oncology, immunotherapy, palliative care, and hematology, while also delving into data and analytics within the health and wellness sector. Erin's work has been featured in Macaroni KID and Healio.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
Erin Michael's articles primarily cover healthcare and pharmaceutical topics, with a significant emphasis on citing data. This suggests she would be interested in pitches based on robust scientific research or data-driven insights. Given her focus, pitching experts who are actively involved in medical research or practitioners with experience applying the latest innovations could be particularly effective.
As her coverage includes industry-specific content and expert commentary, consider offering access to professionals capable of providing nuanced analysis of medical advancements or technological innovations within the healthcare and pharmaceutical sectors.
While Erin's geographic focus is not specified, it seems that she covers global developments in healthcare and pharmaceuticals without specific regional constraints.
This information evolves through artificial intelligence and human feedback. Improve this profile .